Predicting the effect of statins on cancer risk using genetic variants from a Mendelian randomization study in the UK Biobank. (2020)
Attributed to:
UK Biobank (core renewal)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.7554/elife.57191
PubMed Identifier: 33046214
Publication URI: http://europepmc.org/abstract/MED/33046214
Type: Journal Article/Review
Volume: 9
Parent Publication: eLife
ISSN: 2050-084X